文献速递其他结缔组织病

系统性硬化症中PPI难治性GERD由不同的食管和胃动力异常驱动

PPI-refractory GERD in SSc is driven by distinct oesophageal and gastric motility abnormalities.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该单中心回顾性研究纳入30例接受每日两次PPI治疗的系统性硬化症成人患者,整合pH-多通道腔内阻抗监测、高分辨率测压和胃排空显像,发现97%存在难治性GERD,食管动力障碍(80%)与酸清除延迟相关,胃动力障碍(60.7%)与反流发作负担增加相关。

要点

  • SSc接受每日两次PPI者中97%存在难治性GERD,需整合动力评估。
  • 食管动力障碍以无收缩(67%)最常见,与酸清除时间延长相关。
  • 胃动力障碍与24小时反流发作负担增加相关,提示胃潴留机制。

核心结论

  • 在该SSc队列中PPI难治性GERD几乎普遍存在,反映前肠异质性、可量化的异常,包括食管清除受损和胃潴留相关的反流负担增加。

研究设计与样本

  • 单中心回顾性研究纳入30例接受每日两次PPI治疗的SSc成人患者(2021-25年),整合pH/MII监测、高分辨率测压和胃排空显像。

主要发现

  • 67%有PPI难治性反流症状,33%正在接受肺移植前评估。
  • 基于Lyon 2.0分类,29/30例(97%)存在难治性GERD,其中53%为确切证据、43%为临界证据。
  • 食管动力障碍见于80%,最常见为无收缩(67%)。
  • 食管动力障碍与酸清除时间延长相关:2.20(1.15-3.75)vs 1.15(0.43-1.90)min,反流发作持续时间延长:16.60(4.38-40.63)vs 1.95(0.53-20.43)min。
  • 胃动力障碍见于60.7%,与反流发作负担增加相关:51.00(30.00-81.50)vs 25.00(21.00-54.00)次/24h。

关键数值与推荐

  • 难治性GERD依据Lyon 2.0分类判定,29/30例(97%)存在,其中确切证据53%、临界证据43%。

临床怎么用

  • 对SSc接受PPI治疗仍有反流症状者,可考虑整合食管测压和胃排空评估以明确机制。
  • 评估结果可用于风险分层(包括肺移植)并指导超越抑酸的机制靶向治疗。

局限性

  • 单中心回顾性研究,样本量30例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Gastroesophageal reflux disease (GERD) is highly prevalent in SSc and frequently persists despite proton pump inhibitor (PPI) therapy. We aimed to characterize the contribution of oesophageal and gastric dysmotility to PPI-refractory GERD in SSc. METHODS: We conducted a single‑centre, retrospective study of adults with SSc who underwent ambulatory pH-multichannel intraluminal impedance (pH/MII) monitoring while receiving twice‑daily PPI therapy (2021-25). Oesophageal motility (high‑resolution manometry, HREM) and gastric emptying scintigraphy were integrated to examine associations between gastro-oesophageal dysmotility and reflux phenotypes. RESULTS: Thirty patients were included, of whom 67% had PPI-refractory reflux symptoms and 33% were undergoing pre-lung transplantation evaluation. Refractory GERD was present in 29/30 patients (97%) based on Lyon 2.0 classification, with conclusive evidence in 53% and borderline evidence in 43%. Oesophageal dysmotility was identified in 80%, most commonly absent contractility (67%), and was associated with impaired reflux clearance, reflected by longer acid clearance times [2.20 (1.15-3.75) vs 1.15 (0.43-1.90) min] and more prolonged reflux episode duration [16.60 (4.38-40.63) vs 1.95 (0.53-20.43) min]. Gastric dysmotility was identified in 60.7% and was associated with an increased reflux episode burden [51.00 (30.00-81.50) vs 25.00 (21.00-54.00) episodes/24 h]. CONCLUSION: PPI‑refractory GERD is nearly universal in this SSc cohort and reflects heterogeneous, quantifiable abnormalities across the foregut, including impaired oesophageal clearance and increased reflux burden related to gastric retention. These findings support integrated physiologic evaluation to define reflux mechanisms, inform risk stratification (including lung transplantation) and guide targeted, mechanism-based therapies beyond acid suppression.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Alcala-Gonzalez LG, Guillen-Del-Castillo A, Felix-Tellez FA, et al. PPI-refractory GERD in SSc is driven by distinct oesophageal and gastric motility abnormalities. Rheumatology (Oxford). 2026. PMID: 42623142. doi:10.1093/rheumatology/keag451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。